ITRM20050297A1 - Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi. - Google Patents

Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi.

Info

Publication number
ITRM20050297A1
ITRM20050297A1 IT000297A ITRM20050297A ITRM20050297A1 IT RM20050297 A1 ITRM20050297 A1 IT RM20050297A1 IT 000297 A IT000297 A IT 000297A IT RM20050297 A ITRM20050297 A IT RM20050297A IT RM20050297 A1 ITRM20050297 A1 IT RM20050297A1
Authority
IT
Italy
Prior art keywords
immunodepressive
epitope
recognize
directed against
antibodies directed
Prior art date
Application number
IT000297A
Other languages
English (en)
Inventor
Pasquale Annunziata
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Priority to IT000297A priority Critical patent/ITRM20050297A1/it
Priority to US11/916,769 priority patent/US20110200590A1/en
Priority to EP06756319A priority patent/EP1888646A2/en
Priority to PCT/IT2006/000429 priority patent/WO2006131953A2/en
Publication of ITRM20050297A1 publication Critical patent/ITRM20050297A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
IT000297A 2005-06-08 2005-06-08 Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi. ITRM20050297A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000297A ITRM20050297A1 (it) 2005-06-08 2005-06-08 Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi.
US11/916,769 US20110200590A1 (en) 2005-06-08 2006-06-08 Antibodies Directed Against the Myelin Basic Protein Recognising an Epitope of CD64 and Their Use as Immunosuppressants
EP06756319A EP1888646A2 (en) 2005-06-08 2006-06-08 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants
PCT/IT2006/000429 WO2006131953A2 (en) 2005-06-08 2006-06-08 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000297A ITRM20050297A1 (it) 2005-06-08 2005-06-08 Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi.

Publications (1)

Publication Number Publication Date
ITRM20050297A1 true ITRM20050297A1 (it) 2006-12-09

Family

ID=36922080

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000297A ITRM20050297A1 (it) 2005-06-08 2005-06-08 Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi.

Country Status (4)

Country Link
US (1) US20110200590A1 (it)
EP (1) EP1888646A2 (it)
IT (1) ITRM20050297A1 (it)
WO (1) WO2006131953A2 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ734307A (en) 2009-11-11 2020-05-29 Ganymed Pharmaceuticals Ag Antibodies specific for claudin 6 (cldn6)
JP2012130294A (ja) * 2010-12-22 2012-07-12 Tosoh Corp 抗体結合タンパク質およびその製造方法
EP2925779A1 (en) * 2012-11-30 2015-10-07 Institut Pasteur Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
CN105541992A (zh) * 2015-11-04 2016-05-04 武汉云克隆诊断试剂研究所有限公司 人MBP18.5kD变体抗原表位肽及特异性检测试剂盒
CN117209609B (zh) * 2023-11-08 2024-01-30 苏州旭光科星抗体生物科技有限公司 一种抗人cd64膜蛋白的单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643740A (en) * 1983-02-24 1997-07-01 Ronald J. Billing Monoclonal antibody specific for activated lymphocytes and monocytes
KR100255717B1 (ko) * 1991-07-15 2000-05-01 그레이엄 브레레톤 항체의 생산방법
WO1994020127A1 (en) * 1993-03-05 1994-09-15 Cytel Corporation Hla-a2.1 binding peptides and their uses
ATE531732T1 (de) * 2004-03-30 2011-11-15 Yissum Res Dev Co Bi-spezifische antikörper, die auf an reaktionen vom allergischen typ beteiligte zellen zielen, zusammensetzungen und anwendungen davon
AU2005258336A1 (en) * 2004-06-03 2006-01-05 Medarex, Inc. Human monoclonal antibodies to Fc gamma receptor I (CD64)

Also Published As

Publication number Publication date
WO2006131953A3 (en) 2007-01-18
WO2006131953A2 (en) 2006-12-14
EP1888646A2 (en) 2008-02-20
US20110200590A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
EA201100908A1 (ru) Расширенные растворимые полипептиды рн20 и их использование
EA200701918A1 (ru) Белок липокалин
NL300935I2 (nl) guselkumab.
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
BRPI0512235A (pt) polipeptìdeos ligadores de antìgenos e seus usos
TR201901841T4 (tr) Her antikorlarının sabit dozlaması.
NL1033095A1 (nl) Littrow-interferometer.
ATE483732T1 (de) Madcam-antikörper
NO20051199L (no) Rorhandteringsutstyr.
DK2468732T3 (da) 1H-Quinazolin-2,4-dioner
EA200702193A1 (ru) Гликозилирование белков
EA200801180A1 (ru) Селективные пептидные агонисты рецептора vpac2
EA201000258A1 (ru) Новые гербициды
DK1987357T3 (da) Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf
ES1061036Y (es) Protesis discal lumbar.
NO20053147L (no) Forsterkningsring.
ITRM20050297A1 (it) Anticorpi diretti contro la proteina basica della mielina che riconoscono un epitopo del cd64 e uso di essi come immunodepressivi.
ES1284664Y (es) Molinillo.
EA201100662A1 (ru) Убиквитин-специфические протеазы, отвечающие за стабильность mcl-1, и их применения
NO20052107L (no) Rep.
ITRM20050212A1 (it) Anello cefalico per il controllo del mal di testa.
ITRM20050191A1 (it) Vettore adenovirale ricombinante di espressione di proteine della famiglia mdm e usi relativi.
ITRN20050016U1 (it) Struttura combinata.